Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.27B | $4.04B | -43.77% |
Cost of Revenue | $725M | $3.76B | -80.74% |
Operating Income | $-2.7B | $-4.25B | +36.42% |
Net Income | $-2.44B | $-4.93B | +50.50% |
EPS (Basic) | $-6.37 | $-12.89 | +50.58% |
EPS (Diluted) | $-6.37 | $-12.89 | +50.58% |
R&D Expense | $3.42B | $3.44B | -0.52% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $15.8B | $19.45B | -18.75% |
Current Assets | $9.67B | $10.8B | -10.49% |
Total Liabilities | $3.88B | $6B | -35.35% |
Current Liabilities | $2.2B | $4.38B | -49.81% |
Stockholders' Equity | $11.93B | $13.46B | -11.36% |
Cash & Equivalents | $1.64B | $2.93B | -43.93% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-3.83B | $-3.74B | -2.38% |
Investing Cash Flow | $2.49B | $4.74B | -47.55% |
Financing Cash Flow | $59M | $-1.27B | +104.65% |
Share Buybacks | $0 | $1.15B | -100.00% |
D&A | $126M | $414M | -69.57% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -118.9% | -105.2% | -13.75% |
Net Margin | -107.5% | — | — |
ROE | -20.5% | — | — |
ROA | -15.4% | — | — |
Current Ratio | $4.392 | — | — |
Debt to Equity | $0.325 | — | — |
Other companies in Biotechnology